Kamada (KMDA) Other Non-Current Assets (2012 - 2024)
Kamada's (KMDA) quarterly Other Non-Current Assets came in at $112000.0 in Q4 2024, down 96.69% quarter-over-quarter from $3.4 million in Q3 2021.
Analysis
Kamada (KMDA) Other Non-Current Assets (2012 - 2024) Analysis & Trends
Kamada (KMDA) has reported Other Non-Current Assets for 11 consecutive years, with $112000.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Other Non-Current Assets changed N/A year-over-year to $112000.0; the trailing twelve-month figure through Dec 2024 stood at $112000.0 (changed N/A YoY), and the FY2024 full-year result was $112000.0, changed N/A from the prior year.
- Other Non-Current Assets declined to $112000.0 in Q4 2024 per KMDA's latest filing, from $3.4 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.4 million in Q2 2021 and bottomed at $112000.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $1.9 million across 3 years, with a median of $1.3 million in 2020.
- The sharpest annual moves came in 2020 and 2021: Other Non-Current Assets soared 508.05% in 2020, then soared 201.52% in 2021.
- Over 3 years, Other Non-Current Assets stood at $1.6 million in 2020, then surged by 114.88% to $3.4 million in 2021, then sank by 96.69% to $112000.0 in 2024.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $112000.0, $3.4 million, and $3.4 million for Q4 2024, Q3 2021, and Q2 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.39 Bn | 197.40 Bn | 7.24 Bn | 12.98 Bn |
| 2 | Gilead Sciences | 181.14 Bn | 177.96 Bn | 6.22 Bn | 4.75 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 82.91 Bn | 74.91 Bn | 3.93 Bn | 2.31 Bn |
| 5 | Argenx Se | 61.55 Bn | 56.36 Bn | 1.37 Bn | 124.00 Mn |
| 6 | Moderna | 54.39 Bn | 49.25 Bn | 52.00 Mn | 618.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.43 Bn | 31.12 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Biogen | 31.18 Bn | 29.89 Bn | 1.96 Bn | 831.80 Mn |
| 9 | Roivant Sciences | 30.11 Bn | 30.11 Bn | 1.16 Mn | 29.59 Mn |
| 10 | Kamada | 472.70 Mn | 402.57 Mn | 22.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2021 | 3.38 Mn |
| Jun 30, 2021 | 3.41 Mn |
| Mar 31, 2021 | 3.18 Mn |
| Dec 31, 2020 | 1.57 Mn |
| Sep 30, 2020 | 1.08 Mn |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 1.05 Mn |
| Dec 31, 2019 | 352,000.00 |
| Sep 30, 2019 | 178,000.00 |
| Jun 30, 2019 | 174,000.00 |
| Mar 31, 2019 | 174,000.00 |
| Dec 31, 2018 | 174,000.00 |
| Sep 30, 2018 | 176,000.00 |
| Jun 30, 2018 | 173,000.00 |
| Mar 31, 2018 | 173,000.00 |
| Dec 31, 2017 | 49,000.00 |
| Sep 30, 2017 | 443,000.00 |
| Jun 30, 2017 | 404,000.00 |
| Mar 31, 2017 | 372,000.00 |